COMPARISON OF EFFICACY OF 0.5% LEVOBUPIVACAINE AND 0.5% ROPIVACAINE IN ULTRASOUND GUIDED BRACHIAL PLEXUS BLOCK BY SUPRACLAVICULAR APPROACH IN UPPERLIMB ELECTIVE PROCEDURES: A COMPARATIVE, CLINICAL STUDY
European Journal of Molecular & Clinical Medicine,
2022, Volume 9, Issue 3, Pages 10319-10328
Abstract
Introduction: Supraclavicular block is preferred for its rapid onset, reliability and a safetechnique forsurgeries involving the upper limb. Several local anaethetics have
beenusedandproveneffectivewithvariousefficacies.
Aims: To study and compare the efficacy of 0.5% Ropivacaine with 0.5% Levobupivacaine in
supraclavicular brachial plexus block in patients undergoing elective upper limb surgeries.
Materials and methods:
Inourprospectiveclinicalstudy,wecomparedLevobupivacaineandRopivacaineforprovidingsupraclavicularbl
ockin60patients. We demonstrated that a volume of 30 ml of Levobupivacaine and Ropivacinewas
sufficient to provide a satisfactory and a successfulsupraclavicular block withthehelpofultrasoundguidedtechniquekeepinginmindthetoxicdoses.
Results:There were no observable changes in both the groups on comparing the vitalswhichincluded heart
rate, systolic blood pressure, diastolic blood pressure andoxygensaturation. Sensory block onset and
duration in Ropivacaine group was statisticallysignificant.Motor block onset of both were comparable and
did notshowanystatisticalsignificance.. The mean duration of motor blockade were
foundtobesignificantstatistically. The duration of analgesia werefoundtobe statistically significant.
Levobupivacaine providingalonger durationofanalgesia. There were no significant changes in baseline
parameters, heart rate, bloodpressuresandsaturationinboththegroups.
Conclusion: Levobupivacaine would be a better option to choose insupraclavicular brachial plexus
blockwhere prolonged postoperativeanalgesia isrequired.
- Article View: 90
- PDF Download: 116